Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome with cranial bone involvement: Case report and literature review.
Janus kinase inhibitors
SAPHO syndrome synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
cranial bone
palmoplantar pustulosis
Journal
International journal of rheumatic diseases
ISSN: 1756-185X
Titre abrégé: Int J Rheum Dis
Pays: England
ID NLM: 101474930
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
26
04
2023
received:
09
02
2023
accepted:
05
05
2023
medline:
2
11
2023
pubmed:
23
5
2023
entrez:
23
5
2023
Statut:
ppublish
Résumé
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare autoimmune inflammatory disease characterized by osteoarticular and dermatological manifestations. The most common osteoarticular manifestations involve the anterior chest wall, axial skeleton, and long bones. Cranial bone involvement is less reported in SAPHO syndrome. We herein present three cases of SAPHO syndrome with cranial bone involvement, and review the previous literature on similar manifestations. It was revealed that SAPHO syndrome could lead to cranial bone involvement, which could involve the dura mater, leading to hypertrophic pachymeningitis, but the outcome is usually good. Janus kinase inhibitors may be a potential treatment option.
Identifiants
pubmed: 37218535
doi: 10.1111/1756-185X.14740
doi:
Types de publication
Review
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
2304-2309Subventions
Organisme : Construction Project of Clinical Key Specialty in Fengtai of Beijing
Organisme : National Natural Science Foundation of China
ID : 82074246
Informations de copyright
© 2023 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Références
Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. Le syndrome acné pustulose hyperostose ostéite (SAPHO). Résultats d'une enquête nationale. 85 observations [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic. 1987;54(3):187-196.
Liu S, Tang M, Cao Y, Li C. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update. Ther Adv Musculoskelet Dis. 2020;12:1-14.
Rukavina I. SAPHO syndrome: a review. J Child Orthop. 2015;9(1):19-27.
Freyschmidt J, Sternberg A. The bullhead sign: scintigraphic pattern of sternocostoclavicular hyperostosis and pustulotic arthroosteitis. Eur Radiol. 1998;8(5):807-812.
Depasquale R, Kumar N, Lalam RK, et al. SAPHO: what radiologists should know. Clin Radiol. 2012;67(3):195-206.
Hiwatani Y, Miwa H, Kondo T. Aseptic meningitis as a rare manifestation of sapho syndrome. Neurology. 2008;71(20):1645-1647.
Tsugawa J, Ouma S, Fukae J, Tsuboi Y. Recurrent unilateral headache associated with SAPHO syndrome. Intern Med. 2014;53(14):1559-1562.
Oguro E, Kato Y, Takamatsu H, Narazaki M, Kumanogoh A. A case of SAPHO syndrome with the lesions limited to the skull. Rheumatol Adv Pract. 2020;4(2):34.
Shiraishi W, Hayashi S, Iwanaga Y, Murai H, Yamamoto A, Kira J. A case of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome presenting with hypertrophic pachymeningitis. J Neurol Sci. 2015;349(1-2):229-231.
Seno A, Arata J, Matsuura Y, Suemitsu I. Palmoplantar pustulosis with pustulotic arthroosteitis involving temporal osteomyelitis and meningitis. J Dermatol. 2000;27(4):269-272.
DiMeco F, Clatterbuck RE, Li KW, McCarthy EF, Olivi A. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome presenting as a primary calvarial lesion. Case report and review of the literature. J Neurosurg. 2000;93(4):693-697.
Uematsu M, Tobisawa S, Nagao M, Matsubara S, Mizutani T, Shibuya M. Headache as a manifestation of SAPHO syndrome with a lesion extending to the dura mater, parietal bone, and temporal muscle. Rinsho Shinkeigaku. 2012;52(2):106-110.
Hahn LD, Fulbright R, Baehring JM. Hypertrophic pachymeningitis. J Neurol Sci. 2016;367:278-283.
Reith JD, Bauer TW, Schils JP. Osseous manifestations of SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome. Am J Surg Pathol. 1996;20(11):1368-1377.
Colina M, Trotta F. Clinical and radiological characteristics of SAPHO syndrome. Curr Rheumatol Rev. 2013;9(1):22-27.
Schaub S, Sirkis HM, Kay J. Imaging for synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) Syndrome. Rheum Dis Clin North Am. 2016;42(4):695-710.
Kinoshita H, Ishii T, Kamoda H, et al. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome with purely osteolytic, not osteosclerotic lesions mimicking a malignant tumor. Case Rep Rheumatol. 2020;2020:6.
Cheng W, Li F, Tian J, et al. New insights in the treatment of SAPHO syndrome and medication recommendations. J Inflamm Res. 2022;15:2365-2380.
Li Y, Huo J, Cao Y, et al. Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation. Ann Rheum Dis. 2020;79(9):1255-1257.